Chevallard Daniel R.

Officer at VIRX; Chief Financial Officer at Regulus Therapeutics Inc.

Sold, on record
$120k
Dollars the filings state
Form 4 sales
13
Latest Feb 27, 2024
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale VIRXPlan not stated
    Nov 28, 2022 2022

    Sold 3,532 shares at $2.72 ($10k)

    Chevallard Daniel R., CFO and COO

    Sold 4% of holdings ($243k position)85,733 shares left0.9x usual sizeFiling

  2. 2 Form 4 sale VIRXPlan not stated
    Feb 27, 2023 +91 days

    Sold 3,599 shares at $1.68 ($6k)

    Chevallard Daniel R., CFO and COO

    Sold 3.9% of holdings ($156k position)89,023 shares left1x usual sizeFiling

  3. 3 Form 4 sale VIRXNo plan
    May 25, 2023 +87 days

    Sold 3,635 shares at $1.42 ($5k)

    Chevallard Daniel R., CFO and COO

    No 10b5-1 planSold 3.8% of holdings ($136k position)92,277 shares left1x usual sizeFiling

  4. 4 Form 144 notice VIRXNotice
    May 26, 2023 +1 day

    Filed to sell 3,635 shares ($5k)

    Chevallard Daniel R., Officer

    No 10b5-1 plan1x usual sizeFiling

  5. 5 Form 4 sale VIRXNo plan
    Aug 28, 2023 +94 days

    Sold 3,512 shares at $1.45 ($5k)

    Chevallard Daniel R., CFO and COO

    No 10b5-1 planSold 3.5% of holdings ($144k position)95,653 shares left1x usual sizeFiling

  6. 6 Form 4 sale VIRXNo plan
    Nov 28, 2023 +92 days

    Sold 3,720 shares at $0.50 ($2k)

    Chevallard Daniel R., CFO and COO

    No 10b5-1 planSold 3.6% of holdings ($51k position)98,822 shares left1x usual sizeFiling

  7. 7 Form 4 sale VIRXNo plan
    Feb 27, 2024 +91 days

    Sold 3,405 shares at $0.73 ($2k)

    Chevallard Daniel R., CFO and COO

    No 10b5-1 planSold 3.2% of holdings ($77k position)102,306 shares left0.9x usual sizeFollows a Form 144Filing

  8. 8 Form 144 notice VIRXNotice
    Feb 27, 2024 same day

    Filed to sell 3,405 shares ($2k)

    Chevallard Daniel R., Officer

    No 10b5-1 plan0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Chevallard Daniel R.
Source
Feb 27, 2024Feb 27, 2024VIRXOfficerForm 144 notice3,405$2kNoticeSEC
Feb 27, 2024Feb 27, 2024VIRXCFO and COOForm 4 sale3,405$2k3.2%No planSEC
Nov 28, 2023Nov 28, 2023VIRXCFO and COOForm 4 sale3,720$2k3.6%No planSEC
Aug 28, 2023Aug 29, 2023VIRXCFO and COOForm 4 sale3,512$5k3.5%No planSEC
May 26, 2023May 26, 2023VIRXOfficerForm 144 notice3,635$5kNoticeSEC
May 25, 2023May 26, 2023VIRXCFO and COOForm 4 sale3,635$5k3.8%No planSEC
Feb 27, 2023Feb 28, 2023VIRXCFO and COOForm 4 sale3,599$6k3.9%Plan not statedSEC
Nov 28, 2022Nov 29, 2022VIRXCFO and COOForm 4 sale3,532$10k4.0%Plan not statedSEC
Aug 26, 2022Aug 29, 2022VIRXCFO and COOForm 4 sale3,655$15k4.2%Plan not statedSEC
May 26, 2022May 27, 2022VIRXCFO and COOForm 4 sale3,596$7k4.3%Plan not statedSEC
Feb 28, 2022Mar 1, 2022VIRXCFO and COOForm 4 sale3,998$11k5.0%Plan not statedSEC
Nov 29, 2021Nov 29, 2021VIRXCFO and COOForm 4 sale7,579$36k9.4%Plan not statedSEC
Jul 1, 2019Jul 2, 2019Regulus Therapeutics Inc.Chief Financial OfficerForm 4 sale2,669$3k3.3%Plan not statedSEC
May 15, 2019May 16, 2019Regulus Therapeutics Inc.Chief Financial OfficerForm 4 sale10,000$14k11.0%Plan not statedSEC
Apr 1, 2019Apr 3, 2019Regulus Therapeutics Inc.Chief Financial OfficerForm 4 sale3,253$3k25.8%UnusualSEC